Epidemiologic and molecular prognostic review of glioblastoma

JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom… - … , biomarkers & prevention, 2014 - AACR
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …

Epidemiology and outcome of glioblastoma

AF Tamimi, M Juweid - Exon Publications, 2017 - exonpublications.com
Glioblastoma (GBM) is the most aggressive malignant primary brain tumor. With an
incidence rate of 3.19 per 100,000 persons in the United States and a median age of 64 …

Predictive and prognostic factors for gliomas

F Ducray, A Idbaih, XW Wang, C Cheneau… - Expert review of …, 2011 - Taylor & Francis
Despite recent therapeutic advances, gliomas, in particular the most frequent and malignant
glioblastoma, remain devastating tumors and need a better molecular characterization to …

[HTML][HTML] Epidemiology of glioblastoma multiforme–literature review

S Grochans, AM Cybulska, D Simińska, J Korbecki… - Cancers, 2022 - mdpi.com
Simple Summary Glioblastoma multiforme (GBM) is one of the most aggressive
malignancies, accounting for 14.5% of all central nervous system tumors and 48.6% of …

Epidemiology, risk factors, and prognostic factors of gliomas

A Pellerino, M Caccese, M Padovan, G Cerretti… - Clinical and …, 2022 - Springer
Purpose Diffuse gliomas are the most common primary malignant brain tumors in adults.
Many studies analyzed their epidemiology, such as the incidence and mortality. Moreover …

Patient and treatment factors associated with survival among adult glioblastoma patients: a USA population-based study from 2000–2010

IW Pan, SD Ferguson, S Lam - Journal of clinical neuroscience, 2015 - Elsevier
In this study, we utilized the USA surveillance, epidemiology, and end results (SEER)
database to examine factors influencing survival of glioblastoma multiforme (GBM) patients …

Epidemiology of brain tumors

JS Barnholtz-Sloan, QT Ostrom… - Neurologic …, 2018 - neurologic.theclinics.com
Brain and central nervous system (CNS) tumors represent approximately 1% of all newly
diagnosed cancers in the United States, and about 2% of cancer deaths. 1, 2 These are a …

[HTML][HTML] Survival outcomes and prognostic factors in glioblastoma

NF Brown, D Ottaviani, J Tazare, J Gregson, N Kitchen… - Cancers, 2022 - mdpi.com
Simple Summary Glioblastoma is the most common tumour that originates in the brain in
adults. Most of the published data on glioblastoma are from patients in clinical trials who …

[HTML][HTML] Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age

Y Lee, AC Scheck, TF Cloughesy, A Lai, J Dong… - BMC medical …, 2008 - Springer
Background Glioblastomas are the most common primary brain tumour in adults. While the
prognosis for patients is poor, gene expression profiling has detected signatures that can …

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

C Houillier, J Lejeune, A Benouaich‐Amiel… - Cancer, 2006 - Wiley Online Library
BACKGROUND In contrast to oligodendrogliomas, molecular predictors of prognosis have
not been consistently found in glioblastomas. However, genetic studies show that …